Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
Friedrisch JR, Sheehan V, Flanagan JM, Baldan A, Summarell CC, Bittar CM, Friedrisch BK, Wilke II, Ribeiro CB, Daudt LE, da Rocha Silla LM. Friedrisch JR, et al. Among authors: wilke ii. Blood Cells Mol Dis. 2016 Nov;62:32-37. doi: 10.1016/j.bcmd.2016.11.002. Epub 2016 Nov 9. Blood Cells Mol Dis. 2016. PMID: 27838552 Free PMC article.
An Experimental Study Comparing the Expansion of Peripheral Blood Natural Killer (NK) Cells Cultured with Artificial Antigen-Presenting Cells, in the Presence or Absence of Bone Marrow Mesenchymal Stem Cells (MSCs).
Pedroso JF, de Souza Valim V, Pezzi A, Furlan JM, Lenhart G, Sehn F, Zambonato B, Gonçalves AD, Wilke I, Amorin B, da Silva MA, Pedrazzani FS, da Rocha Silla LM. Pedroso JF, et al. Mol Biotechnol. 2020 May;62(5):306-315. doi: 10.1007/s12033-020-00250-2. Mol Biotechnol. 2020. PMID: 32193710
Adoptive immunotherapy with double-bright (CD56bright /CD16bright ) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study.
Silla L, Valim V, Pezzi A, da Silva M, Wilke I, Nobrega J, Vargas A, Amorin B, Correa B, Zambonato B, Scherer F, Merzoni J, Sekine L, Huls H, Cooper LJ, Paz A, Lee DA. Silla L, et al. Br J Haematol. 2021 Dec;195(5):710-721. doi: 10.1111/bjh.17751. Epub 2021 Sep 7. Br J Haematol. 2021. PMID: 34490616 Clinical Trial.
The proteomic and particle composition of human platelet lysate for cell therapy products.
Rodrigues RM, Valim VS, Berger M, da Silva APM, Fachel FNS, Wilke II, da Silva WOB, Santi L, da Silva MAL, Amorin B, Sehn F, Yates JR 3rd, Guimarães JA, Silla L. Rodrigues RM, et al. Among authors: wilke ii. J Cell Biochem. 2022 Sep;123(9):1495-1505. doi: 10.1002/jcb.30310. Epub 2022 Jul 26. J Cell Biochem. 2022. PMID: 35892149